HK Stock MarketDetailed Quotes

02410 TYK MEDICINES-B

Watchlist
  • 25.500
  • +5.620+28.27%
Market Closed Nov 8 16:08 CST
9.46BMarket Cap-20174P/E (TTM)

TYK MEDICINES-B Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
Cash flow from operating activities
Earning before tax
-26.28%-219.53M
-29.52%-107.78M
-22.89%-383.17M
-30.79%-266.18M
---173.85M
---83.21M
---311.8M
---203.52M
Profit adjustment
Interest expense - adjustment
20.64%3.67M
23.77%1.79M
194.63%6.37M
241.12%4.69M
--3.04M
--1.44M
--2.16M
--1.37M
Investment loss (gain)
84.56%-372K
99.23%-12K
43.44%-3.03M
29.75%-2.95M
---2.41M
---1.57M
---5.35M
---4.2M
Revaluation surplus:
22.59%47.2M
21.72%23.44M
14.17%78.52M
16.58%58.09M
--38.5M
--19.26M
--68.77M
--49.83M
-Other fair value changes
22.59%47.2M
21.72%23.44M
14.17%78.52M
16.58%58.09M
--38.5M
--19.26M
--68.77M
--49.83M
Asset sale loss (gain):
----
----
-72.97%10K
-118.92%-7K
--3K
----
--37K
--37K
-Loss (gain) on sale of property, machinery and equipment
----
----
-72.97%10K
-118.92%-7K
--3K
----
--37K
--37K
Depreciation and amortization:
6.37%14.73M
8.97%7.33M
69.28%27.64M
99.73%21.38M
--13.85M
--6.72M
--16.33M
--10.71M
-Amortization of intangible assets
-0.04%2.83M
-0.07%1.41M
-0.02%5.66M
0.00%4.24M
--2.83M
--1.42M
--5.66M
--4.24M
Financial expense
22.22%1.76M
-17.15%575K
18.90%15.87M
-85.20%1.89M
--1.44M
--694K
--13.34M
--12.75M
Exchange Loss (gain)
114.89%21K
----
---7K
---47K
---141K
----
----
----
Special items
656.67%16.15M
763.95%9.12M
407.30%5.81M
-281.31%-4.47M
---2.9M
---1.37M
---1.89M
---1.17M
Operating profit before the change of operating capital
-11.36%-136.38M
-12.94%-65.54M
-15.38%-251.99M
-39.80%-187.61M
---122.47M
---58.04M
---218.4M
---134.2M
Change of operating capital
Accounts receivable (increase)decrease
116.51%1.76M
36.01%-6.85M
42.49%-11.27M
86.63%-6.56M
---10.66M
---10.7M
---19.6M
---49.09M
Accounts payable increase (decrease)
-105.59%-1.66M
-198.09%-11.53M
1,374.38%62.32M
765.41%37.63M
--29.69M
--11.75M
---4.89M
--4.35M
Special items for working capital changes
----
----
----
----
----
----
--22.83M
----
Cash  from business operations
-31.74%-136.28M
-47.26%-83.92M
8.68%-200.94M
12.51%-156.55M
---103.44M
---56.99M
---220.05M
---178.93M
Special items of business
----
----
----
----
----
----
----
--22.83M
Net cash from operations
-31.74%-136.28M
-47.26%-83.92M
8.68%-200.94M
-0.28%-156.55M
---103.44M
---56.99M
---220.05M
---156.1M
Cash flow from investment activities
Decrease in deposits (increase)
---60M
---60M
120.03%1.17M
----
----
----
---5.84M
----
Sale of fixed assets
--4.76M
--4.76M
3,250.00%67K
--3K
----
----
--2K
----
Purchase of fixed assets
63.55%-18.27M
42.21%-18.07M
-29.53%-76.38M
-84.00%-67.96M
---50.12M
---31.26M
---58.97M
---36.93M
Recovery of cash from investments
-83.40%91.37M
-98.21%6.01M
-35.42%758.03M
-27.35%738.95M
--550.41M
--336.57M
--1.17B
--1.02B
Cash on investment
71.00%-138M
73.67%-75M
51.87%-609.88M
44.91%-604.88M
---475.88M
---284.88M
---1.27B
---1.1B
Net cash from investment operations
-592.16%-120.14M
-796.56%-142.29M
146.16%73.01M
156.16%66.12M
--24.41M
--20.43M
---158.17M
---117.73M
Net cash before financing
-224.44%-256.42M
-518.78%-226.21M
66.17%-127.94M
66.98%-90.42M
---79.03M
---36.56M
---378.22M
---273.83M
Cash flow from financing activities
New borrowing
42.15%92.4M
--80.4M
----
62.50%65M
--65M
----
----
--40M
Issuing shares
--50M
--50M
-43.08%185M
-90.77%30M
----
----
--325M
--325M
Interest paid - financing
---864K
---73K
----
----
----
----
----
----
Issuance expenses and redemption of securities expenses
---11.27M
---24.7M
22.23%-9.53M
----
----
----
---12.25M
---12.25M
Other items of the financing business
-11.07%-15.61M
-80.95%10.96M
26.40%48.52M
-3,698.24%-15.08M
---14.06M
--57.54M
--38.39M
---397K
Net cash from financing operations
125.06%114.65M
102.62%116.59M
-36.21%224M
-77.32%79.92M
--50.94M
--57.54M
--351.14M
--352.35M
Effect of rate
-114.89%-21K
----
--7K
--47K
--141K
----
----
----
Net Cash
-404.65%-141.77M
-622.43%-109.62M
454.74%96.06M
-113.38%-10.5M
---28.09M
--20.98M
---27.08M
--78.52M
Begining period cash
105.85%186.83M
105.85%186.83M
-22.98%90.76M
-22.98%90.76M
--90.76M
--90.76M
--117.84M
--117.84M
Cash at the end
-28.29%45.04M
-30.91%77.21M
105.85%186.83M
-59.10%80.31M
--62.81M
--111.75M
--90.76M
--196.36M
Cash balance analysis
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
--
--
Unqualified Opinion
--
--
--
Unqualified Opinion
--
Auditor
--
--
Ernst & Young
--
--
--
Ernst & Young
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022
Cash flow from operating activities
Earning before tax -26.28%-219.53M-29.52%-107.78M-22.89%-383.17M-30.79%-266.18M---173.85M---83.21M---311.8M---203.52M
Profit adjustment
Interest expense - adjustment 20.64%3.67M23.77%1.79M194.63%6.37M241.12%4.69M--3.04M--1.44M--2.16M--1.37M
Investment loss (gain) 84.56%-372K99.23%-12K43.44%-3.03M29.75%-2.95M---2.41M---1.57M---5.35M---4.2M
Revaluation surplus: 22.59%47.2M21.72%23.44M14.17%78.52M16.58%58.09M--38.5M--19.26M--68.77M--49.83M
-Other fair value changes 22.59%47.2M21.72%23.44M14.17%78.52M16.58%58.09M--38.5M--19.26M--68.77M--49.83M
Asset sale loss (gain): ---------72.97%10K-118.92%-7K--3K------37K--37K
-Loss (gain) on sale of property, machinery and equipment ---------72.97%10K-118.92%-7K--3K------37K--37K
Depreciation and amortization: 6.37%14.73M8.97%7.33M69.28%27.64M99.73%21.38M--13.85M--6.72M--16.33M--10.71M
-Amortization of intangible assets -0.04%2.83M-0.07%1.41M-0.02%5.66M0.00%4.24M--2.83M--1.42M--5.66M--4.24M
Financial expense 22.22%1.76M-17.15%575K18.90%15.87M-85.20%1.89M--1.44M--694K--13.34M--12.75M
Exchange Loss (gain) 114.89%21K-------7K---47K---141K------------
Special items 656.67%16.15M763.95%9.12M407.30%5.81M-281.31%-4.47M---2.9M---1.37M---1.89M---1.17M
Operating profit before the change of operating capital -11.36%-136.38M-12.94%-65.54M-15.38%-251.99M-39.80%-187.61M---122.47M---58.04M---218.4M---134.2M
Change of operating capital
Accounts receivable (increase)decrease 116.51%1.76M36.01%-6.85M42.49%-11.27M86.63%-6.56M---10.66M---10.7M---19.6M---49.09M
Accounts payable increase (decrease) -105.59%-1.66M-198.09%-11.53M1,374.38%62.32M765.41%37.63M--29.69M--11.75M---4.89M--4.35M
Special items for working capital changes --------------------------22.83M----
Cash  from business operations -31.74%-136.28M-47.26%-83.92M8.68%-200.94M12.51%-156.55M---103.44M---56.99M---220.05M---178.93M
Special items of business ------------------------------22.83M
Net cash from operations -31.74%-136.28M-47.26%-83.92M8.68%-200.94M-0.28%-156.55M---103.44M---56.99M---220.05M---156.1M
Cash flow from investment activities
Decrease in deposits (increase) ---60M---60M120.03%1.17M---------------5.84M----
Sale of fixed assets --4.76M--4.76M3,250.00%67K--3K----------2K----
Purchase of fixed assets 63.55%-18.27M42.21%-18.07M-29.53%-76.38M-84.00%-67.96M---50.12M---31.26M---58.97M---36.93M
Recovery of cash from investments -83.40%91.37M-98.21%6.01M-35.42%758.03M-27.35%738.95M--550.41M--336.57M--1.17B--1.02B
Cash on investment 71.00%-138M73.67%-75M51.87%-609.88M44.91%-604.88M---475.88M---284.88M---1.27B---1.1B
Net cash from investment operations -592.16%-120.14M-796.56%-142.29M146.16%73.01M156.16%66.12M--24.41M--20.43M---158.17M---117.73M
Net cash before financing -224.44%-256.42M-518.78%-226.21M66.17%-127.94M66.98%-90.42M---79.03M---36.56M---378.22M---273.83M
Cash flow from financing activities
New borrowing 42.15%92.4M--80.4M----62.50%65M--65M----------40M
Issuing shares --50M--50M-43.08%185M-90.77%30M----------325M--325M
Interest paid - financing ---864K---73K------------------------
Issuance expenses and redemption of securities expenses ---11.27M---24.7M22.23%-9.53M---------------12.25M---12.25M
Other items of the financing business -11.07%-15.61M-80.95%10.96M26.40%48.52M-3,698.24%-15.08M---14.06M--57.54M--38.39M---397K
Net cash from financing operations 125.06%114.65M102.62%116.59M-36.21%224M-77.32%79.92M--50.94M--57.54M--351.14M--352.35M
Effect of rate -114.89%-21K------7K--47K--141K------------
Net Cash -404.65%-141.77M-622.43%-109.62M454.74%96.06M-113.38%-10.5M---28.09M--20.98M---27.08M--78.52M
Begining period cash 105.85%186.83M105.85%186.83M-22.98%90.76M-22.98%90.76M--90.76M--90.76M--117.84M--117.84M
Cash at the end -28.29%45.04M-30.91%77.21M105.85%186.83M-59.10%80.31M--62.81M--111.75M--90.76M--196.36M
Cash balance analysis
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions ----Unqualified Opinion------Unqualified Opinion--
Auditor ----Ernst & Young------Ernst & Young--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
% Chg

No Data